$Phase IB study of cabozantinib in patients with relapsed and/or refractory multiple myeloma$

Phase IB study of cabozantinib in patients with relapsed and/or refractory multiple myeloma

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Blood 2016-05, Vol.127 (19), p.2355-2356
Hauptverfasser:	Lendvai, Nikoletta, Yee, Andrew J., Tsakos, Ioanna, Alexander, Aeri, Devlin, Sean M., Hassoun, Hani, Korde, Neha, Lesokhin, Alexander M., Landau, Heather, Mailankody, Sham, Koehne, Guenther, Chung, David J., Landgren, Ola, Raje, Noopur S., Giralt, Sergio
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Anilides - therapeutic use Female Humans Letters to Male Middle Aged Multiple Myeloma - drug therapy Neoplasm Recurrence, Local - drug therapy Protein Kinase Inhibitors - therapeutic use Pyridines - therapeutic use Receptor Protein-Tyrosine Kinases - antagonists & inhibitors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!